Navigation Links
ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
Date:6/19/2008

MEMPHIS, Tenn., June 19 /PRNewswire/ -- Accelerated Community Oncology Research Network(TM) (ACORN) will be showcasing its oncology-focused CRO and research network; Guardian EDC(TM); PACE(TM) PRO System; and proprietary oncology-focused data warehouse at the 44th Annual DIA Meeting, June 22-26, in Boston, MA.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO )

In March, 2008 the company announced its Contract Research Organization (CRO) exceeded performance expectations over the previous 12 months. ACORN's CRO provides a full-range of research services to sponsors, from clinical trial design to site selection to the results phase with bioanalysis and findings presentation. ACORN's member network provides core strength to CRO operations and is recognized for its exceptional recruitment of minority trial participants at more than double the national average.

With the company's recent announcement that its Oncology Data Warehouse accumulated nearly 50 million data observations from over 110,000 oncology patients in its data warehouse, ACORN(TM) is poised as a leader in providing reliable information solutions to payers, financial institutions, pharmaceutical / biotech companies, and community oncology practices.

Additionally, ACORN's accrual of over one million comprehensive physical and psychological cancer patient assessments obtained via PACE(TM) (Patient Assessment Care and Education) and continued market uptake of Guardian EDC(TM) (web-based electronic data capture) demonstrates its continued leadership in capturing unique electronic data into a single platform for easy access across the full range of data elements and conducting scientific analysis to generate reliable information solutions in the oncology industry.

Analytical data from ACORN's oncology data repository has been presented at many major oncology-related confere
'/>"/>

SOURCE Accelerated Community Oncology Research Network, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. ACORNs Oncology-focused Contract Research Organization Exceeds Projections
2. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
3. ACORN Continues Success in Oncology Data Warehousing With Accumulation of Nearly 50 Million Data Observations
4. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
5. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
6. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
10. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
11. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, Dec...ssfully Inhibits miR-122, a microRNA Important for...tly Reducing Hepatitis C,Virus in the Bloodstream ...itis C Virus , - SPC3649 Demonstrates Eff...Serious Adverse Events in the Treated Animals - Si...
(Date:12/3/2009)... Dec. 3 Cardium Therapeu...holly-owned subsidiary, Tissue Repair Company, sub... the U.S. Food and Drug Administration (FDA) seeki...duct candidate based on positive data from the Com... study. Today,s submission with the FDA covers Ex...
(Date:12/3/2009)...alif., Dec. 3 Jazz Pharm...that Kathryn E. Falberg has been appointed Senior ...alberg brings to Jazz Pharmaceuticals more than 20...e. As Jazz Pharmaceutical,s CFO, Ms. Falberg will...orate finance, financial planning, investor relati...
Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 1Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 2Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 3Get Ready for Gruesome Cigarette Warnings 55508 1Get Ready for Gruesome Cigarette Warnings 55508 2Get Ready for Gruesome Cigarette Warnings 55508 3Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 1Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 2
...Form Medical,Inc. (Nasdaq: BFRM ) today announced...nded comparative study of nasolabial fold treatmen...Radiesse(R) dermal filler,than reported after trea...results of this study were published in the Decemb...c Surgery, a peer-reviewed publication of the,Amer...
...ent in Motor Function at 24 Months, SAN DIEGO, De...llow-up data from a Phase 1 clinical trial of CERE...ase. CERE-120 uses gene therapy to,deliver the neu...eurodegeneration that occurs in the brains of Park...ssments at 18 and 24 months post,treatment, sugges...
Other Medicine Technology:Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 2Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 3Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 4
(Date:12/3/2009)... Evaluation and Treatment Clinic...stock (Vocus) December 3, 2009 -- Centegra Health ...and H1N1 vaccine shots at four Centegra Primary Ca...ent of vaccine has arrived. The clinics are at CPC...enry and will be open as follows: ,   F...
(Date:12/3/2009)... new findings, doubts linger about whether they ca...(HealthDay News) -- Whether cell phones cause brai... a new study confirms previous evidence suggesting...e incidents of brain tumors in Scandinavia found n... phone use became widespread, according to the rep...
(Date:12/3/2009)... , LONDON, Dec. 3 Chiltern I... research organization (CRO) providing clinical de...ricas and Asia, today announces the appointment of...lobal Quality & Medical Affairs. Dr. Moore is .... ,, Dr. Moore is a physician with 15 years of ...
(Date:12/3/2009)..., PHOENIX, Dec. 3 The day has co...he nation,s most prominent direct-care RN organiza...r the founding convention of the new 150,000-membe... professional association in U.S. history. ,, A...note address to the convention which will chart a ...
(Date:12/3/2009)... , Recent CBO analysis understates key fact...ec. 3 A new actuarial a...nnual medical claims in the new individual market ... years after implementation of healthcare reform u...t (PPACA), excluding the impact of medical inflati...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics Continue 2Health News:Centegra H1N1 Vaccination Clinics Continue 3Health News:Centegra H1N1 Vaccination Clinics Continue 4Health News:No Increase in Brain Tumors Seen From Cell Phones 2Health News:No Increase in Brain Tumors Seen From Cell Phones 3Health News:Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs 2Health News:RN SuperUnion Founding Convention Opens Monday 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4
...healthcare advisory services firm, announced today...s Karpook and Gregory Maddrey to the position of,P...ng healthcare,organizations in advancing their str...and Pam are senior advisors with vast industry,exp...
...ol Shootings, LOS ANGELES, March 5 On February 1...th shooter in the past,decade under the influence ...rug regulatory agencies to cause suicide, mania, p...ling 54,dead and 105 wounded, the mental health wa...
...at 8:00 am, the Bowen Foundation for Autism will h...s to raise money to fight autism. For a,registrati...tiful 5K,waterfront course complete with activitie...e awareness and resources for,the prevention, trea...
...in Your Teeth, VOORHEES, N.J., March 5 Federal t...imilar for 2007. Together with the,government,s ec...,200 or,more back in the pockets of most taxpayers...investment with that money. According to Dr. Jack ...
...duced at all NHS Hospital Trusts a study by resear...at smoking is still prevalent, even by staff in un...ealth Sciences conclude that effective enforcement...moking on site. , The study was carried out to d...
...ime reasons why, study finds , , WEDNESDAY...gers in automobiles that crash are more likely to ...ecially if the car is being driven by a young, ine...ers in this age group died in car crashes. , "We w...
Other Medicine News:Health News:The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal 2Health News:The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal 3Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 2Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 3Health News:Inaugural Bowen Foundation Run/Walk to Fight Autism in Maryland Set for Saturday, March 29 2Health News:Smile When You Get that Refund 2Health News:Hospitals still not smoke-free 2Health News:Teen Passengers at Higher Death Risk in Car Crashes 2Health News:Teen Passengers at Higher Death Risk in Car Crashes 3
Streck-Kleen Enzymatic Cleanser
Streck-Diluent III Plus Balanced Electrolyte Solution
Streck-CN free Lyse CD Lytic Reagent
...ted red blood cell (nRBC) control for evaluating t... 755 hematology analyzer in its enumeration of the...r LH 750/LH 755. nRBC-Chex for LH is a two-level c...nRBC-Chex for LH has a 75-day closed-vial stabilit...
Medicine Products: